A phase 1 study of everolimus and sorafenib for metastatic clear cell renal cell carcinoma (Q46189130)
scientific article
Language:
Current Data About A phase 1 study of everolimus and sorafenib for metastatic clear cell renal cell carcinoma
(P31) (Q13442814)
(P248)
(P698) 21387258
(P813) Wednesday, December 20, 2017
(P854) http://europepmc.org/abstract/MED/21387258

(P50) (Q97531370)
(P1545) 2
(P1932) Eric J Small
(P248)
(P698) 21387258
(P813) Wednesday, December 20, 2017
(P854) http://europepmc.org/abstract/MED/21387258

(P304) 4194-4200
(P248)
(P698) 21387258
(P813) Wednesday, December 20, 2017
(P854) http://europepmc.org/abstract/MED/21387258

(P407) (Q1860)

(P433) 18
(P248)
(P698) 21387258
(P813) Wednesday, December 20, 2017
(P854) http://europepmc.org/abstract/MED/21387258

(P478) 117
(P248)
(P698) 21387258
(P813) Wednesday, December 20, 2017
(P854) http://europepmc.org/abstract/MED/21387258

(P577) Tuesday, March 8, 2011
(P248)
(P698) 21387258
(P813) Wednesday, December 20, 2017
(P854) http://europepmc.org/abstract/MED/21387258

(P1104) 7
(P887)

(P1433) (Q326041)
(P248)
(P698) 21387258
(P813) Wednesday, December 20, 2017
(P854) http://europepmc.org/abstract/MED/21387258

(P1476) "A phase 1 study of everolimus and sorafenib for metastatic clear cell renal cell carcinoma" (language: en)
(P248)
(P698) 21387258
(P813) Wednesday, December 20, 2017
(P854) http://europepmc.org/abstract/MED/21387258

(P2093) Andrea L Harzstark
(P1545) 1
(P248)
(P698) 21387258
(P813) Wednesday, December 20, 2017
(P854) http://europepmc.org/abstract/MED/21387258

Vivian K Weinberg
(P1545) 3
(P248)
(P698) 21387258
(P813) Wednesday, December 20, 2017
(P854) http://europepmc.org/abstract/MED/21387258

Janine Sun
(P1545) 4
(P248)
(P698) 21387258
(P813) Wednesday, December 20, 2017
(P854) http://europepmc.org/abstract/MED/21387258

Charles J Ryan
(P1545) 5
(P248)
(P698) 21387258
(P813) Wednesday, December 20, 2017
(P854) http://europepmc.org/abstract/MED/21387258

Amy M Lin
(P1545) 6
(P248)
(P698) 21387258
(P813) Wednesday, December 20, 2017
(P854) http://europepmc.org/abstract/MED/21387258

Lawrence Fong
(P1545) 7
(P248)
(P698) 21387258
(P813) Wednesday, December 20, 2017
(P854) http://europepmc.org/abstract/MED/21387258

Dion R Brocks
(P1545) 8
(P248)
(P698) 21387258
(P813) Wednesday, December 20, 2017
(P854) http://europepmc.org/abstract/MED/21387258

Jonathan E Rosenberg
(P1545) 9
(P248)
(P698) 21387258
(P813) Wednesday, December 20, 2017
(P854) http://europepmc.org/abstract/MED/21387258

(P2860) (Q37117085)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.25931
(P813) Sunday, January 21, 2018

(Q34021957)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.25931
(P813) Sunday, January 21, 2018

(Q28282767)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.25931
(P813) Sunday, January 21, 2018

(Q28282757)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.25931
(P813) Sunday, January 21, 2018

(Q29615711)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.25931
(P813) Sunday, January 21, 2018

(Q53390981)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.25931
(P813) Sunday, January 21, 2018

(Q45238764)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.25931
(P813) Sunday, January 21, 2018

(Q29618031)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.25931
(P813) Sunday, January 21, 2018

(Q27860904)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.25931
(P813) Sunday, January 21, 2018

(Q44732861)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.25931
(P813) Sunday, January 21, 2018

(Q33880227)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.25931
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article

External Links
(P356) 10.1002/CNCR.25931
(P698) 21387258
(P5875) 50349359